Mark Zuckerberg and his wife Priscilla Chan have donated $25 million through their foundation to a philanthropic effort organized by Bill Gates to explore new coronavirus treatments. 

The Gates Foundation donated $50 million last week to what it’s calling the “COVID-19 Therapeutics Accelerator.” The initiative brings together life sciences companies to collaborate on the development of new vaccines, diagnostics, and treatments for COVID-19.

“The Therapeutics Accelerator will enable researchers to quickly determine whether or not existing drugs have a potential benefit against COVID-19,” Chan and Zuckerberg said in a press release. “We hope these coordinated efforts will help stop the spread of COVID-19 as well as provide shared, reusable strategies to respond to future pandemics.”

The two donations are the largest from tech billionaires since the coronavirus outbreak. Wellcome and Mastercard are supporting the effort as well. 

The goal of the initiative is to either develop a new drug or adapt an existing treatment that it could help distribute alongside partnering pharmaceutical companies. 

The 15 companies participating in the project kicked off the effort by sharing their proprietary libraries of molecular compounds that have some history of being tested with COVID-19. 

The lineup includes big names in biotech such as Johnson & Johnson, Merck, Pfizer, Sanofi, and Bristol-Myers Squibb. 

Share:
More In Technology
CarDekho Raises $250 Million in Pre-IPO Round
The largest car search platform in India, Cardekho, recently raised $250 million in what the company calls a pre-IPO round led by leapfrog investments. The funding bumps CarDekho above unicorn status with a $1.2 billion valuation. The company currently has a catalogue of more than 3,000 pre-owned cars for online purchases and hopes to expand with the new funding. Partner and co-head of South Asian investment for LeapFrog Stewart Langdon joins Cheddar News' Closing Bell to discuss.
E-Scooter Company Bird Goes Public to Scale Up Its Environmental Impact
E-scooter company Bird made its public debut on the New York Stock Exchange on Thursday. CFO Yibo Ling joined Cheddar to discuss what made the company launch a SPAC IPO now. Ling noted one of the deciding factors was the need to scale the business to help take "gas-guzzling cars off the road" by growing into more locations. "A large portion of our proceeds will go to fund expansion into these new geographies," he said.
Load More